TECregen
PrivateLast Round
Seed
Jan 8, 2026
Total Funding Raised
$12.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
TECregen is a biotechnology company developing a new class of biologics, called thymopoietics, designed to regenerate the thymus and restore immune function.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TECregen Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
TECregen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 8, 2026 |
Key People
Founding team and executive leadership
TECregen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JFG Life Sciences Foundation of the University of Basel | Seed |
| Boehringer Ingelheim Venture Fund | Seed |
| LifeSpan Vision Ventures | Seed |
| CARMA FUND | Seed |
| High-Tech Gründerfonds | Seed |
| Eos | Seed |
| Zurcher Kantonalbank | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2026
Grew 30% QoQ, from 10 to 13 employees.
- Jan 30, 2026
Dr. Klaas Zuideveld appointed as new Chief Executive Officer.
TECregen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TECregen's valuation, stock price, and market status.